Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease
- 1 September 2009
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 214 (1-2), 128-131
- https://doi.org/10.1016/j.jneuroim.2009.07.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosisJournal of Neuroimmunology, 2008
- Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjectscclm, 2008
- Association of the HLA-DRB1⁎15 allele group and the DRB1⁎1501 and DRB1⁎1503 alleles with multiple sclerosis in White and Mulatto samples from BrazilJournal of Neuroimmunology, 2007
- Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosisMultiple Sclerosis Journal, 2006
- MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon betaClinical Neurology and Neurosurgery, 2005
- Definition and Clinical Importance of HaplotypesAnnual Review of Medicine, 2005
- MMP-9 microsatellite polymorphism and multiple sclerosisJournal of Neuroimmunology, 2004
- Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypesJournal of Neuroimmunology, 2003
- Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon‐β therapy in relapsing and secondary‐progressive multiple sclerosis patientsAnnals of Neurology, 2001